skip to main content

Antiepileptic brand continuity — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateDispensing and SupplyAntiepileptic brand continuityGPhC CRA

A prescription for carbamazepine modified-release tablets is presented for a patient who previously received a different modified-release brand. The patient has epilepsy and has been seizure-free for years. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: C — Check brand continuity and consult the prescriber if a change is proposed

Carbamazepine is an antiepileptic where continuity of supply from the same manufacturer's product may be important for some patients. Changes in formulation or brand can affect seizure control or adverse effects. The pharmacist should check previous supply and prescriber intention.

Reference: BNF; MHRA safety advice